Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Talcosis due to abundant use of cosmetic talcum powder

A. van Huisstede, V. Noordhoek Hegt, I. Otte-Holler, M. Looijen-Salamon, A. Rudolphus
European Respiratory Review 2010 19: 165-168; DOI: 10.1183/09059180.00001310
A. van Huisstede
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
V. Noordhoek Hegt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
I. Otte-Holler
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Looijen-Salamon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Rudolphus
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

To the Editor:

A 36-yr-old, nonsmoking, Hindustan female presented with complaints of dyspnoea without coughing which had persisted for several months. The complaints started after a bout of pneumonia a few months previously. Her medical history was unremarkable. She did not suffer from asthma, nor did asthma run in the family. She worked at an administrative office. Physical examination showed no abnormalities; in particular, the auscultation of the lungs was normal. A screening laboratory examination, including complete blood count, renal function and liver function tests, was normal. A chest radiograph showed nodular lesions in both lungs (fig. 1a⇓).

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

Radiodiagnostic imaging. a) A chest radiograph showing multiple nodular lesions in both lungs. b) A high-resolution computed tomography scan showing a diffuse nodular image in both lungs. Interlobular septa and pleura were normal.

Because of the abnormal chest radiograph, a second patient history was carried out and revealed a remarkable twice daily bathing ritual where she used large amounts of cosmetic talcum powder. After bathing the patient powdered her whole body with talcum powder, a ritual she had carried out since her childhood. Ancillary laboratory investigations including angiotensin converting enzyme, total immunoglobulin E and anti-cyclic citrullinated peptide were all negative. A high-resolution computed tomography (CT) scan of the thorax showed a diffuse nodular image in both lungs. Interlobular septa and pleura showed a normal pattern (fig. 1b⇑). Pulmonary function tests showed a restrictive pattern, with a normal diffusion capacity. Bronchoscopy did not reveal any endobronchial abnormalities. Bronchoalveolar lavage was negative for mycobacteria and other infectious agents, and no neoplastic cells were found. Inflammatory cell distribution was normal, including a CD4/CD8 ratio of 0.9 (normal <2.5). Transbronchial lung biopsies showed patchy peribronchiolar fibrosis and an extensive non-caseating granulomatous inflammation with numerous multinucleair giant cells associated with the massive presence of needle-shaped birefringent crystalline material (fig. 2a and b⇓). Pulmonary vessels showed no abnormalities. No asbestos bodies were observed.

FIGURE 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2.

Transbronchial lung biopsy microscopic slide of a) lung tissue showing a granulomatous inflammation with giant cell reaction and b) lung tissue under polarised light (birefringed crystalline material). c) Scanning transmission electron micrograph of the lung biopsy specimen showing sheets and fibres. In this area five different points were selected with the point and shoot utility. Points 1–4: electron dense crystalline material; point 5: control area. Scale bar = 100 nm. d) Energy-dispersive spectroscopy spectrum of point 1, all crystals in the lung biopsy specimen showed peaks for magnesium (Mg) and silicon (Si) in a ratio consistent with talc. Reference measurements such as point 5, however, showed only peaks for copper (Cu), originating from the copper carrier grid.

For tissue analysis by energy-dispersive X-ray spectroscopy (EDX), haematoxylin and eosin stained sections of paraffin embedded lung specimens were screened for birefringent crystals. Small areas were chosen from the paraffin blocks, dissected, de-paraffinised and then embedded in Epon according to Luft's procedure (Merck, Darmstadt, Germany). Ultra-thin sections (200 nm) were cut on an ultra-microtome (Leica Microsystems, Wetzlar, Germany) and examined in a 1200 EXII electronmicroscope (Jeol, Tokyo, Japan). For generation of the EDX spectra, the scanning transmission electron microscope mode was used. Spectra of the chosen areas were generated with the point and shoot utility using the tracor northern system 6 detector (Thermo Noran, Middleton, WI, USA). Ultra structural examination of these birefringent crystals was performed in the electronmicroscope (1200EX II; Jeol) for morphology, localisation and diffraction pattern. Extracellular sheets and fibres were found in extensive amounts (fig. 2c⇑). EDX analysis of the crystals in the lung biopsy specimen showed particles of magnesium, silicon and sporadical chlorine. The structure of these particles, together with the presence of magnesium and silicon, was consistent with talc (fig. 2d⇑).

Based on the patient's history and the clinical, radiological, histological and mineralogical findings, and by the exclusion of other plausible causes, the diagnosis of talc induced interstitial lung disease (talcosis) was made based on abundant use of cosmetic talcum powder. At 1-yr follow-up the patient had discontinued her bathing ritual; the complaints had decreased and pulmonary function had increased. The chest radiograph did not show an improvement and the nodular lesions in both lungs remained unchanged.

Pulmonary disease due to talc is almost exclusively encountered secondary to occupational exposure or intravenous drug abuse. Talcosis or talc pneumoconiosis is one of the rarer forms of silicate induced lung disease. It has been described in workers exposed to talc during its production or its industrial use. Very often, the history of exposure is not recognised by the patient. However, talcosis can also be caused due to the use of cosmetic talcum powder. High-purity talc is used in cosmetic and pharmaceutical industries and there is no conclusive evidence that cosmetic talc, when used as intended, presents a health hazard [1].

In 1979 Wells et al. [2] described a case which shows remarkable parallels with this case report. The patient was in the habit of dusting the whole body with talc at least once daily and the talc had been applied in a small unventilated room likely to favour inhalation [2]. However, it was Thorel [3] who reported the first case of talc pneumoconiosis in 1896. Following this there have been several written reports of talcosis due to cosmetic talcum powder; however, the course can be quite different [4–9]. Despite these reports the prevalence of talcosis due to the abundant use of cosmetic talcum powder is not as high as could be expected according to the common use of cosmetic talcum powder.

Radiographic findings may include generalised haziness, nodulation and reticulation similar to those observed in asbestosis, but the apices and costophrenic sulci are generally spared in talcosis. As in other forms of pneumoconiosis, nodule confluence results in large opacities that resemble those in progressive massive fibrosis. In some patients, hilar lymphadenopathy develops. High-resolution CT scan findings in patients with talcosis caused by inhaled particulates include small centrilobular and subpleural nodules and heterogeneous conglomerate masses with internal foci of high attenuation that are consistent with talc deposition [10]. In our patient, the size and location of the nodules supports the diagnosis of talcosis.

Apart from a patient history, a biopsy is necessary to make the diagnosis. The pathological features of talc inhalation have been described as either fibrosis reaction, which can be diffuse interstitial or irregular nodular, or as non-caseating granulomatous reaction. Microscopic examination under polarised light reveals birefringent needle-shaped particles in multinucleated giant cells and macrophages. These pathological features differ from pulmonary findings seen after intravenous talc injection. In pulmonary findings seen after intravenous talc injection the particles are larger and characteristic intravascular and perivascular granulomas can be seen [4]. In our patient, the size of the particles, the location of the granulomas and the lack of intravascular and perivascular lesions support inhalation as mode of entry of the talc into the lungs.

This case emphasises the importance of a thorough medical history. On basis of the patient's history and the compatible clinical, radiological, histological and mineralogical findings, as well as the exclusion of other plausible causes, a diagnosis of talcosis due to abundant cosmetic talcum powder was made.

Statement of interest

None declared.

Provenance

Submitted article, peer reviewed.

    • © ERS

    References

    1. ↵
      Wehner A. Biological effects of cosmetic talc. Food Chem Toxicol 1994; 32: 1173–1184.
      OpenUrlCrossRefPubMed
    2. ↵
      Wells IP, Dubbins PA, Whimster WF. Pulmonary disease caused by the inhalation of cosmetic talcum powder. Br J Radiol 1979; 52: 586–588.
      OpenUrlAbstract/FREE Full Text
    3. ↵
      Thorel C. Talc lung: a contribution to the pathological anatomy of pneumoconiosis. Beitr Pathol Anat Allgem Pathol 1896; 20: 85–101.
      OpenUrl
    4. ↵
      Dekel Y, Rath-Wolfson L, Rudniki C, et al. Talc inhalation is a life-threatening condition. Pathol Oncol Res 2004; 10: 231–233.
      OpenUrlPubMed
    5. Egan AJ, Tazelaar HD, Myers JL, et al. Munchausen syndrome presenting as pulmonary talcosis. Arch Pathol Lab Med 1999; 123: 736–738.
      OpenUrlPubMed
    6. Abraham JL, Brambilla C. Particle size for differentiation between inhalation and injection pulmonary talcosis. Environ Res 1980; 21: 94–96.
      OpenUrlPubMed
    7. Cotton WH, Davidson PJ. Aspiration of baby powder. N Engl J Med 1985; 313: 1662
      OpenUrlPubMed
    8. Hollinger MA. Pulmonary toxicity of inhaled and intravenous talc. Toxicol Lett 1990; 52: 121–127.
      OpenUrlCrossRefPubMed
    9. ↵
      Nam K, Gracey DR. Pulmonary talcosis from cosmetic talcum powder. JAMA 1972; 221: 492–493.
      OpenUrlCrossRefPubMed
    10. ↵
      Chong S, Lee KS, Chung MJ, et al. Pneumoconiosis: comparison of imaging and pathologic findings. Radiographics 2006; 26: 59–77.
      OpenUrlPubMed
    PreviousNext
    Back to top
    View this article with LENS
    Vol 19 Issue 116 Table of Contents
    • Table of Contents
    • Index by author
    Email

    Thank you for your interest in spreading the word on European Respiratory Society .

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Talcosis due to abundant use of cosmetic talcum powder
    (Your Name) has sent you a message from European Respiratory Society
    (Your Name) thought you would like to see the European Respiratory Society web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Print
    Citation Tools
    Talcosis due to abundant use of cosmetic talcum powder
    A. van Huisstede, V. Noordhoek Hegt, I. Otte-Holler, M. Looijen-Salamon, A. Rudolphus
    European Respiratory Review Jun 2010, 19 (116) 165-168; DOI: 10.1183/09059180.00001310

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Talcosis due to abundant use of cosmetic talcum powder
    A. van Huisstede, V. Noordhoek Hegt, I. Otte-Holler, M. Looijen-Salamon, A. Rudolphus
    European Respiratory Review Jun 2010, 19 (116) 165-168; DOI: 10.1183/09059180.00001310
    Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
    Full Text (PDF)

    Jump To

    • Article
      • Statement of interest
      • Provenance
      • References
    • Figures & Data
    • Info & Metrics
    • PDF
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    More in this TOC Section

    • Reply to: “Nicotine or tobacco abstinence?”
    • Nicotine or tobacco abstinence?
    • Biochemical shunt: where and how?
    Show more Correspondence

    Related Articles

    Navigate

    • Home
    • Current issue
    • Archive

    About the ERR

    • Journal information
    • Editorial board
    • Press
    • Permissions and reprints
    • Advertising
    • Sponsorship

    The European Respiratory Society

    • Society home
    • myERS
    • Privacy policy
    • Accessibility

    ERS publications

    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS books online
    • ERS Bookshop

    Help

    • Feedback

    For authors

    • Instructions for authors
    • Publication ethics and malpractice
    • Submit a manuscript

    For readers

    • Alerts
    • Subjects
    • RSS

    Subscriptions

    • Accessing the ERS publications

    Contact us

    European Respiratory Society
    442 Glossop Road
    Sheffield S10 2PX
    United Kingdom
    Tel: +44 114 2672860
    Email: journals@ersnet.org

    ISSN

    Print ISSN: 0905-9180
    Online ISSN: 1600-0617

    Copyright © 2023 by the European Respiratory Society